Active and latent tuberculosis among HIV‐positive injecting drug users in Indonesia

Authors:

Abstract
Introduction: Injecting drug use (IDU) is associated with tuberculosis but few data are available from low‐income settings. We examined IDU in relation to active and latent tuberculosis (LTBI) among HIV‐positive individuals in Indonesia, which has a high burden of tuberculosis and a rapidly growing HIV epidemic strongly driven by IDU.Methods: Active tuberculosis was measured prospectively among 1900 consecutive antiretroviral treatment (ART)‐naïve adult patients entering care in a clinic in West Java. Prevalence of LTBI was determined cross‐sectionally in a subset of 518 ART‐experienced patients using an interferon‐gamma release assay.Results: Patients with a history of IDU (53.1%) more often reported a history of tuberculosis treatment (34.8% vs. 21.9%, p<0.001), more often received tuberculosis treatment during follow‐up (adjusted HR=1.71; 95% CI: 1.25–2.35) and more often had bacteriologically confirmed tuberculosis (OR=1.67; 95% CI: 0.94–2.96). LTBI was equally prevalent among people with and without a history of IDU (29.1 vs. 30.4%, NS). The risk estimates did not change after adjustment for CD4 cell count or ART.Conclusions: HIV‐positive individuals with a history of IDU in Indonesia have more active tuberculosis, with similar rates of LTBI. Within the HIV clinic, LTBI screening and isoniazid preventive therapy may be prioritized to patients with a history of IDU.
Funding Information
  • European Commission (SANTE/2005/105‐033)
  • Radboud Universiteit

This publication has 40 references indexed in Scilit: